InvestorsHub Logo
icon url

surf1944

04/05/12 9:36 AM

#41 RE: surf1944 #39

1:09AM Regeneron Pharms and Sanofi (SNY) receives Priority Review of the Biologics License Application for the investigational agent ZALTRAP from the FDA (REGN) 6.22 :